2'-O-(2-methoxy)ethyl-modified anti-intercellular adhesion molecule 1 (ICAM-1) oligonucleotides selectively increase the ICAM-1 mRNA level and inhibit formation of the ICAM-1 translation initiation complex in human umbilical vein endothelial cells

被引:317
作者
Baker, BF
Lot, SS
Condon, TP
ChengFlournoy, S
Lesnik, EA
Sasmor, HM
Bennett, CF
机构
[1] Isis Pharmaceuticals, Inc., Carlsbad
[2] Isis Pharmaceuticals, Inc., Carlsbad, CA 92008
关键词
D O I
10.1074/jbc.272.18.11994
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Little is known about the mechanisms that account for inhibition of gene expression by antisense oligonucleotides at the level of molecular cell biology, For this purpose, we have selected potent 2'-O-(a-methoxy) ethyl antisense oligonucleotides (IC50 = 2 and 6 nM) that target the 5' cap region of the human intercellular adhesion molecule 1 (ICAM-1) transcript to determine their effects upon individual processes of mRNA metabolism in HUVECs. Given the functions of the 5' cap structure throughout mRNA metabolism, antisense oligonucleotides that target the 5' cap region of a target transcript have the potential to modulate one or more metabolic stages of the message inside the cell. In this study we found that inhibition of protein expression by these RNase H independent antisense oligonucleotides was not due to effects on splicing or transport of the ICAM-1 transcript, but due instead to selective interference with the formation of the 80 S translation initiation complex. Interestingly, these antisense oligonucleotides also caused an increase in ICAM-1 mRNA abundance in the cytoplasm. These results imply that ICAM-1 mRNA turnover is coupled in part to translation.
引用
收藏
页码:11994 / 12000
页数:7
相关论文
共 57 条
[1]   ADHESION MOLECULES AND INFLAMMATORY INJURY [J].
ALBELDA, SM ;
SMITH, CW ;
WARD, PA .
FASEB JOURNAL, 1994, 8 (08) :504-512
[2]  
[Anonymous], ANTISENSE RES APPL
[3]   5'-TERMINAL CAP STRUCTURE IN EUKARYOTIC MESSENGER RIBONUCLEIC-ACIDS [J].
BANERJEE, AK .
MICROBIOLOGICAL REVIEWS, 1980, 44 (02) :175-205
[4]   ADVANCES IN THE SYNTHESIS OF OLIGONUCLEOTIDES BY THE PHOSPHORAMIDITE APPROACH [J].
BEAUCAGE, SL ;
IYER, RP .
TETRAHEDRON, 1992, 48 (12) :2223-2311
[5]   BINDING OF PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES TO BASIC FIBROBLAST GROWTH-FACTOR, RECOMBINANT SOLUBLE CD4, LAMININ AND FIBRONECTIN IS P-CHIRALITY INDEPENDENT [J].
BENIMETSKAYA, L ;
TONKINSON, JL ;
KOZIOLKIEWICZ, M ;
KARWOWSKI, B ;
GUGA, P ;
ZELTSER, R ;
STEC, W ;
STEIN, CA .
NUCLEIC ACIDS RESEARCH, 1995, 23 (21) :4239-4245
[6]  
Bennett C F, 1994, Adv Pharmacol, V28, P1, DOI 10.1016/S1054-3589(08)60492-5
[7]  
BENNETT CF, 1992, MOL PHARMACOL, V41, P1023
[8]  
BENNETT CF, 1994, J IMMUNOL, V152, P3530
[9]  
BENNETT CF, 1996, THERAPEUTIC MODULATI, P171
[10]  
BERGER SL, 1989, METHOD ENZYMOL, V180, P3